Bruce A. Keyt
Net Worth

Last updated:

What is Bruce A. Keyt net worth?

The estimated net worth of Dr. Bruce A. Keyt is at least $6,639,149 as of 13 Sep 2024. He owns shares worth $310,973 as insider, has earned $3,146,526 from insider trading and has received compensation worth at least $3,181,650 in IGM Biosciences, Inc..

What is the salary of Bruce A. Keyt?

Dr. Bruce A. Keyt salary is $636,330 per year as Chief Scientific Officer in IGM Biosciences, Inc..

How old is Bruce A. Keyt?

Dr. Bruce A. Keyt is 72 years old, born in 1953.

What stocks does Bruce A. Keyt currently own?

As insider, Dr. Bruce A. Keyt owns shares in one company:

Company Title Shares Price per share Total value
IGM Biosciences, Inc. (IGMS) Chief Scientific Officer 242,948 $1.28 $310,973

What does IGM Biosciences, Inc. do?

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGMS logo
IGMS
IGM Biosciences, Inc.
$1.28

Bruce A. Keyt insider trading

IGM Biosciences, Inc.

Dr. Bruce A. Keyt has made 36 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,487 units of IGMS stock worth $17,158 on 13 Sep 2024.

The largest trade he's ever made was exercising 33,756 units of IGMS stock on 5 Jan 2023. As of 13 Sep 2024 he still owns at least 242,948 units of IGMS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,487 $11.54 $17,158
Sale
Common Stock 1,106 $7.58 $8,378
Sale
Common Stock 933 $5.06 $4,720
Sale
Common Stock 970 $12.3 $11,932
Sale
Common Stock 12 $13.01 $156
Sale
Common Stock 1,293 $18.73 $24,220
Option
Stock Option (right to buy) 33,756 $0.93 $31,393
Option
Common Stock 33,756 $0.93 $31,393
Sale
Common Stock 1,917 $19.36 $37,113
Sale
Common Stock 3,454 $18.78 $64,849
Option
Common Stock 25,000 $0.93 $23,250
Option
Stock Option (right to buy) 25,000 $0.93 $23,250
Sale
Common Stock 277 $21.99 $6,092
Sale
Common Stock 600 $21.38 $12,826
Option
Stock Option (right to buy) 25,000 $0.93 $23,250
Sale
Common Stock 25,000 $22.84 $570,975
Option
Common Stock 25,000 $0.93 $23,250
Option
Stock Option (right to buy) 10,000 $0.93 $9,300
Option
Common Stock 10,000 $0.93 $9,300
Sale
Common Stock 7,265 $19.57 $142,198
Sale
Common Stock 2,735 $20.34 $55,633
Option
Common Stock 10,000 $0.93 $9,300
Option
Stock Option (right to buy) 10,000 $0.93 $9,300
Sale
Common Stock 10,000 $19.04 $190,390
Option
Common Stock 5,000 $0.93 $4,650
Sale
Common Stock 5,000 $19.06 $95,320
Option
Stock Option (right to buy) 5,000 $0.93 $4,650
Option
Stock Option (right to buy) 6,300 $0.93 $5,859
Sale
Common Stock 6,300 $20.71 $130,454
Option
Common Stock 6,300 $0.93 $5,859
Option
Common Stock 8,700 $0.93 $8,091
Option
Stock Option (right to buy) 8,700 $0.93 $8,091
Sale
Common Stock 8,700 $22.82 $198,543
Option
Stock Option (right to buy) 10,000 $0.93 $9,300
Sale
Common Stock 10,000 $22.54 $225,350
Option
Common Stock 10,000 $0.93 $9,300
Sale
Common Stock 939 $17.1 $16,059
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 2,500 $25 $62,500
Option
Stock Option (right to buy) 7,500 $0.93 $6,975
Sale
Common Stock 7,500 $28.5 $213,728
Option
Common Stock 7,500 $0.93 $6,975
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Sale
Common Stock 1,326 $51.37 $68,117
Option
Common Stock 2,500 $0.93 $2,325
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Sale
Common Stock 1,242 $64.1 $79,617
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 1,244 $70.69 $87,932
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 1,242 $67 $83,214
Option
Common Stock 2,500 $0.93 $2,325
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Sale
Common Stock 1,247 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Stock Option (right to buy) 2,500 N/A N/A
Sale
Common Stock 1,245 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Stock Option (right to buy) 2,500 N/A N/A
Sale
Common Stock 1,243 $62.5 $77,688
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 1,254 $82 $102,828
Option
Common Stock 2,500 $0.93 $2,325
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Sale
Common Stock 1,619 $90.25 $146,115
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 1,619 $96 $155,424
Option
Common Stock 2,500 $0.93 $2,325
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Sale
Common Stock 1,503 $79.33 $119,233
Sale
Common Stock 883 $88.07 $77,766
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 N/A N/A
Sale
Common Stock 1,618 N/A N/A
Option
Stock Option (right to buy) 2,500 $0.93 $2,325
Option
Common Stock 2,500 $0.93 $2,325
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 $60 $60,000
Option
Stock Option (right to buy) 2,987 $20.83 $62,219
Option
Common Stock 2,987 $20.83 $62,219

IGM Biosciences key executives

IGM Biosciences, Inc. executives and other stock owners filed with the SEC: